The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia

Clinical Cancer Research

Volumn 17, Issue 21, 2011, Pages 6778-6790

  Ouillette, Peter ^b   Collins, Roxane ^b   Shakhan, Sajid ^b   Li, Jinghui ^b   Li, Cheng ^a   Shedden, Kerby ^c   Malek, Sami N ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME DELETION; CHROMOSOME DELETION 13Q14; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DOSAGE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; RB1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CENTROMERE; CHROMOSOME BREAKPOINTS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 14; COHORT STUDIES; FEMALE; FRAMESHIFT MUTATION; GENE DOSAGE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; SURVIVAL RATE; TELOMERE;

EID: 80455140244     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-0785     Document Type: Article

References (39)

1. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-6. (Pubitemid 32064784)
2. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia.NEngl J Med 2005;352:804-15.
3. Shanafelt TD, Hanson C, Dewald GW, Witzig TE, LaPlant B, Abrahamzon J, et al. Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression. J Clin Oncol 2008;26:e5-6.
4. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990;323:720-4. (Pubitemid 20288941)
5. Peterson LC, Lindquist LL, Church S, Kay NE. Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: multiple clones, subclones, and nonclonal alterations in 82midwestern patients. Genes Chromosomes Cancer 1992;4:273-80.
6. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed JC, et al. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 1996;88:3109-15. (Pubitemid 26357394)
7. Liu Y, Hermanson M, Grander D, Merup M,WuX, Heyman M, et al. 13q deletions in lymphoid malignancies. Blood 1995;86:1911-5.
8. Rowntree C, Duke V, Panayiotidis P, Kotsi P, Palmisano GL, Hoffbrand AV, et al. Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia 2002;16:1267-75.
9. Wolf S, Mertens D,Schaffner C, Korz C, Dohner H, Stilgenbauer S, et al. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 2001;10:1275-85. (Pubitemid 32600481)
10. Rondeau G, Moreau I, Bezieau S, Petit JL, Heilig R, Fernandez S, et al. Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus. Mutat Res 2001;458:55-70. (Pubitemid 33016657)
11. Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 2001;97:2098-104. (Pubitemid 32239092)
12. Mabuchi H, Fujii H, Calin G, Alder H, Negrini M, Rassenti L, et al. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res 2001;61:2870-7. (Pubitemid 32691928)
13. Kitamura E, Su G, Sossey-Alaoui K, Malaj E, Lewis J, Pan HQ, et al. A transcription map of the minimally deleted region from 13q14 in B-cell chronic lymphocytic leukemia as defined by large scale sequencing of the 650 kb critical region. Oncogene 2000;19:5772-80.
14. Kapanadze B, Makeeva N, Corcoran M, Jareborg N, Hammarsund M, Baranova A, et al. Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. Genomics 2000;70:327-34. (Pubitemid 32095431)
15. Grubor V, Krasnitz A, Troge JE, Meth JL, Lakshmi B, Kendall JT, et al. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). Blood 2009;113:1294-303.
16. Mosca L, Fabris S, Lionetti M, Todoerti K, Agnelli L, Morabito F, et al. Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion. Clin Cancer Res 2010;16:5641-53.
17. Parker H, Rose-Zerilli MJ, Parker A, Chaplin T, Wade R, Gardiner A, et al. 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. Leukemia 2011;25:489-97.
18. Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008;68: 1012-21. (Pubitemid 351272218)
19. Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 2007;109: 1202-10. (Pubitemid 46220669)
20. Liu Y, Grander D, Soderhall S, Juliusson G, Gahrton G, Einhorn S. Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 1992;4:250-6.
21. Liu Y, Szekely L, Grander D, Soderhall S, Juliusson G, Gahrton G, et al. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci U S A 1993;90:8697-701. (Pubitemid 23277737)
22. Dohner H, Pilz T, Fischer K, Cabot G, Diehl D, Fink T, et al. Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias. Leuk Lymphoma 1994;16:97-103.
23. Stilgenbauer S, Dohner H, Bulgay-Morschel M, Weitz S, Bentz M, Lichter P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 1993;81:2118-24. (Pubitemid 23106727)
24. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-7. (Pubitemid 26189840)
25. Kujawski L, Ouillette P, Erba H, Saddler C, Jakubowiak A, Kaminski M, et al. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia. Blood 2008;112:1993-2003.
26. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 2004;20:1233-40. (Pubitemid 38807579)
27. Parkin B, Erba H, Ouillette P, Roulston D, Purkayastha A, Karp J, et al. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia. Blood 2010;116:4958-67.
28. Long J, Parkin B, Ouillette P, Bixby D, Shedden K, Erba H, et al. Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia. Blood 2010;116:71-80.
29. Bouyge-Moreau I, Rondeau G, Avet-Loiseau H, Andre MT, Bezieau S, Cherel M, et al. Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3. Genomics 1997;46:183-90. (Pubitemid 28013414)
30. Kalachikov S, Migliazza A, Cayanis E, Fracchiolla NS, Bonaldo MF, Lawton L, et al. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 1997;42:369-77. (Pubitemid 27287376)
31. Palamarchuk A, Efanov A, Nazaryan N, Santanam U, Alder H, Rassenti L, et al. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 2010;115:3916-22.
32. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007;109:4944-51. (Pubitemid 46827793)
33. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9. (Pubitemid 35403967)
34. Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC, et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007;109:5079-86. (Pubitemid 46890521)
35. Ouillette P, Fossum S, Parkin B, Ding L, Bockenstedt P, Al-Zoubi A, et al. Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks. Clin Cancer Res 2010;16:835-47.
36. Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, Talpaz M, et al. Acquired copy number aberrations and survival in chronic lymphocytic leukemia. Blood 2011;118:3051-61.
37. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, et al. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Br J Haematol 2010;148:544-50.
38. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression frommitotic control. Nature 2004;430:797-802. (Pubitemid 39071352)
39. HammarsundM, CorcoranMM, Wilson W, Zhu C, Einhorn S, Sangfelt O, et al. Characterization of a novel B-CLL candidate gene-DLEU7-located in the 13q14 tumor suppressor locus. FEBS Lett 2004;556:75-80. (Pubitemid 38058558)